Towards purification of adenoviral vectors based on membrane technology.
about
Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophagesProduction of adenovirus vectors and their use as a delivery system for influenza vaccines.Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration.Plant-derived virus-like particles as vaccinesVirus-like particles in vaccine development.Recent developments in membrane-based separations in biotechnology processes: review.Downstream processing of cell culture-derived virus particles.Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.Bioprocess development for canine adenovirus type 2 vectors.Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification.Enhanced sensitivity of an antibody competitive blocking enzyme-linked immunosorbent assay using Equine arteritis virus purified by anion-exchange membrane chromatography.Designing clinical-grade integrated strategies for the downstream processing of human mesenchymal stem cells.Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo.Development of a platform process for adenovirus purification that removes human SET and nucleolin and provides high purity vector for gene delivery.Virus-Like Particle Bioprocessing
P2860
Q28082234-E96B3FCD-FEE3-4281-B792-6A8B93B8E298Q30226988-8C527ED3-CBC7-4899-B01D-3301FE293624Q35535220-D9F3B8B5-0285-4AB8-9C51-AF2D466B0B51Q36888029-3103E743-EBA8-470B-83E4-C65A93346FE9Q37798008-C1C9BAAE-A472-4202-94CA-47CA1333EAD6Q37941805-5A4DFC41-FDF7-4B14-BB4C-4067CF4669C2Q37944322-05E6B0D2-E11F-424C-A1A2-C4A82AD35B36Q38443390-C44A7925-C6A3-4D4B-8F22-820179229B12Q39319692-F1B67825-778B-4241-8443-FDDB1828AC60Q39597963-367DFB43-1CFA-448F-892C-29D74DD8015DQ40954734-6F247ADB-CB02-42D2-8796-B6070CE33E3DQ45860983-2FBCED3A-675F-4C33-846D-3D13F75EAF70Q45875626-FF438413-F1AB-4207-9AF6-E2795A40A9D5Q45882344-3753F5C2-53D4-429A-BEF8-702E6C5033BFQ58476143-CB7FDE2B-F53E-44AA-A587-E015C96049A6
P2860
Towards purification of adenoviral vectors based on membrane technology.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Towards purification of adenoviral vectors based on membrane technology.
@en
Towards purification of adenoviral vectors based on membrane technology.
@nl
type
label
Towards purification of adenoviral vectors based on membrane technology.
@en
Towards purification of adenoviral vectors based on membrane technology.
@nl
prefLabel
Towards purification of adenoviral vectors based on membrane technology.
@en
Towards purification of adenoviral vectors based on membrane technology.
@nl
P50
P356
P1476
Towards purification of adenoviral vectors based on membrane technology.
@en
P2093
Marcos F Q Sousa
Tiago B Ferreira
P304
P356
10.1002/BTPR.25
P577
2008-11-01T00:00:00Z